Gilbert Lynn Marks - 10 Jul 2025 Form 4 Insider Report for AN2 Therapeutics, Inc. (ANTX)

Role
Director
Signature
/s/ Lucy Day, Attorney-in-Fact for Gilbert Lynn Marks
Issuer symbol
ANTX
Transactions as of
10 Jul 2025
Net transactions value
$0
Form type
4
Filing time
11 Jul 2025, 18:20:48 UTC
Previous filing
23 May 2025
Next filing
14 Oct 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Marks Gilbert Lynn Director C/O AN2 THERAPEUTICS, INC., 1800 EL CAMINO REAL, SUITE D, MENLO PARK /s/ Lucy Day, Attorney-in-Fact for Gilbert Lynn Marks 11 Jul 2025 0001916940

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANTX Common Stock Award $0 +11,875 +29% $0.000000 53,382 10 Jul 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares issued in lieu of cash compensation under the issuer's non-employee director compensation policy. All shares vest immediately.